Search Results - "Mitsuoka, Eisei"

Emergency surgery for hemobilia due to hepatic artery pseudoaneurysm rupture complicated by Mirizzi syndrome type II: a case report by Shishido, Yutaka, Fujimoto, Koji, Yano, Yasumichi, Mitsuoka, Eisei, Komatsubara, Takashi, Shio, Seiji, Ishii, Masayuki, Higashiyama, Hiroshi

“…Abstract Background Hemobilia refers to bleeding into the biliary tract. Hepatic artery pseudoaneurysm (HAP) rupture is an uncommon cause of hemobilia, and…”
Get full text

Cholecystoduodenal fistula caused by aggressive mucinous gallbladder carcinoma with a porcelain gallbladder by Matsumoto, Yoshihide, Fujimoto, Koji, Mitsuoka, Eisei, Senda, Eri, Shio, Seiji, Ichikawa, Kazuhito, Yamada, Hajime

“…Cholecystoduodenal fistula secondary to gallbladder carcinoma (GBC) is extremely rare and develops when the tumor penetrates into the adjacent duodenum. A…”
Get full text

Metastatic colorectal cancer responsive to regorafenib for 2 years: a case report by Yoshino, Kenji, Manaka, Dai, Kudo, Ryo, Kanai, Shunpei, Mitsuoka, Eisei, Kanto, Satoshi, Hamasu, Shinya, Konishi, Sayuri, Nishitai, Ryuta

“…Regorafenib is an oral multikinase inhibitor that has been demonstrated as clinically effective in patients with metastatic colorectal cancer in phase III…”
Get full text

Fistula formation into other organs secondary to intraductal papillary mucinous neoplasm of the pancreas: A case report and literature review by Shishido, Yutaka, Mitsuoka, Eisei, Ito, Rieko, Ishii, Masayuki, Fujimoto, Koji

“…Fistula formation from intraductal papillary mucinous neoplasm (IPMN) of the pancreas is uncommon; however, IPMN penetrating various organs has been…”
Get full text

Successful Administration of Regorafenib to a Metastatic Colon Cancer Patient with Impaired Performance Status by Reducing the Initial Dose by Nishitai, Ryuta, Manaka, Dai, Kudo, Ryo, Mitsuoka, Eisei, Kanai, Shumpei, Kanto, Satoshi, Yoshino, Kenji, Hamasu, Shin-ya, Konishi, Sayuri, Yamashiro, Yutaka

“…A 59-year-old woman had recurrences in the spleen and lung 10 years after radical excision of cecal cancer. After 27 months of treatment with…”
Get more information

Duodenal ulcer bleeding from a branch of the middle colic artery: A case report by Shishido, Yutaka, Mitsuoka, Eisei, Tanigawa, Yuma, Ooki, Hodaka, Shio, Seiji, Monzawa, Shuichi, Ishii, Masayuki, Fujimoto, Koji

“…Rationale: Duodenal ulcer bleeding is a potentially life-threatening condition commonly caused by the erosion of the duodenal arteries. Patient concerns: A…”
Get full text

Clinical Implications and Risk Factors of Dilatation of Remnant Pancreatic Duct at 1 Year after Pancreatoduodenectomy: A Prospective, Japanese, Multicenter, Observational Cohort Study (DAIMONJI Study) by Narita, Masato, Hatano, Etsuro, Kitamura, Koji, Terajima, Hiroaki, Kitagawa, Hirohisa, Mitsuoka, Eisei, Machimoto, Takafumi, Morita, Satoshi, Nishitai, Ryuta, Masui, Toshihiko

“…To determine the precise frequency of main pancreatic duct (MPD) dilatation within the remnant pancreas at 1 year after pancreatoduodenectomy (PD) and its…”
Get full text

Pancreatoduodenectomy in a patient with celiac axis stenosis and a replaced common hepatic artery: A case report by Komatsubara, Takashi, Fujimoto, Koji, Tanigawa, Yuma, Mitsuoka, Eisei, Isii, Masayuki

“…Evaluation of anatomical variations is important in pancreatoduodenectomy (PD) because an arterial anomaly is a risk factor for morbidity. Herein, we report a…”
Get full text

Phase II study of Ccr-based dose-control of S-1 in 1st line SOX + bevacizumab regimen for advanced colorectal cancer by Manaka, Dai, Nishitai, Ryuta, Konishi, Sayuri, Hamasu, Shinya, Yoshino, Kenji, Kantou, Satoshi, Kanai, Shunpei, Mitsuoka, Eisei, Kudo, Ryo

Get full text